| CD8 T cell score as a prognostic biomarker for triple negative breast cancer M Oshi, M Asaoka, Y Tokumaru, L Yan, R Matsuyama, T Ishikawa, I Endo, ... International journal of molecular sciences 21 (18), 6968, 2020 | 192 | 2020 |
| M1 Macrophage and M1/M2 ratio defined by transcriptomic signatures resemble only part of their conventional clinical characteristics in breast cancer M Oshi, Y Tokumaru, M Asaoka, L Yan, V Satyananda, R Matsuyama, ... Scientific reports 10 (1), 16554, 2020 | 176 | 2020 |
| G2M cell cycle pathway score as a prognostic biomarker of metastasis in estrogen receptor (ER)-positive breast cancer M Oshi, H Takahashi, Y Tokumaru, L Yan, OM Rashid, R Matsuyama, ... International journal of molecular sciences 21 (8), 2921, 2020 | 141 | 2020 |
| The E2F pathway score as a predictive biomarker of response to neoadjuvant therapy in ER+/HER2− breast cancer M Oshi, H Takahashi, Y Tokumaru, L Yan, OM Rashid, M Nagahashi, ... Cells 9 (7), 1643, 2020 | 113 | 2020 |
| KRAS signaling enriched triple negative breast cancer is associated with favorable tumor immune microenvironment and better survival Y Tokumaru, M Oshi, E Katsuta, L Yan, V Satyananda, N Matsuhashi, ... American journal of cancer research 10 (3), 897, 2020 | 109 | 2020 |
| Abundance of regulatory T cell (Treg) as a predictive biomarker for neoadjuvant chemotherapy in triple-negative breast cancer M Oshi, M Asaoka, Y Tokumaru, FA Angarita, L Yan, R Matsuyama, ... Cancers 12 (10), 3038, 2020 | 101 | 2020 |
| Urine as a source of liquid biopsy for cancer M Oshi, V Murthy, H Takahashi, M Huyser, M Okano, Y Tokumaru, ... Cancers 13 (11), 2652, 2021 | 96 | 2021 |
| Plasmacytoid dendritic cell (pDC) infiltration correlate with tumor infiltrating lymphocytes, cancer immunity, and better survival in triple negative breast cancer (TNBC) more … M Oshi, S Newman, Y Tokumaru, L Yan, R Matsuyama, P Kalinski, I Endo, ... Cancers 12 (11), 3342, 2020 | 88 | 2020 |
| Intra-tumoral angiogenesis is associated with inflammation, immune reaction and metastatic recurrence in breast cancer M Oshi, S Newman, Y Tokumaru, L Yan, R Matsuyama, I Endo, ... International journal of molecular sciences 21 (18), 6708, 2020 | 79 | 2020 |
| Current status and limitations of immunotherapy for breast cancer Y Tokumaru, D Joyce, K Takabe Surgery 167 (3), 628-630, 2020 | 77 | 2020 |
| G2M checkpoint pathway alone is associated with drug response and survival among cell proliferation-related pathways in pancreatic cancer M Oshi, A Patel, L Le, Y Tokumaru, L Yan, R Matsuyama, I Endo, ... American journal of cancer research 11 (6), 3070, 2021 | 59 | 2021 |
| Degree of early estrogen response predict survival after endocrine therapy in primary and metastatic ER-positive breast cancer M Oshi, Y Tokumaru, FA Angarita, L Yan, R Matsuyama, I Endo, K Takabe Cancers 12 (12), 3557, 2020 | 56 | 2020 |
| High G2M pathway score pancreatic cancer is associated with worse survival, particularly after margin-positive (R1 or R2) resection M Oshi, S Newman, Y Tokumaru, L Yan, R Matsuyama, I Endo, MHG Katz, ... Cancers 12 (10), 2871, 2020 | 56 | 2020 |
| Enhanced DNA repair pathway is associated with cell proliferation and worse survival in hepatocellular carcinoma (HCC) M Oshi, TH Kim, Y Tokumaru, L Yan, R Matsuyama, I Endo, L Cherkassky, ... Cancers 13 (2), 323, 2021 | 54 | 2021 |
| Intratumoral adipocyte-high breast cancer enrich for metastatic and inflammation-related pathways but associated with less cancer cell proliferation Y Tokumaru, M Oshi, E Katsuta, L Yan, JL Huang, M Nagahashi, ... International journal of molecular sciences 21 (16), 5744, 2020 | 53 | 2020 |
| Inflammation Is Associated with Worse Outcome in the Whole Cohort but with Better Outcome in Triple‐Negative Subtype of Breast Cancer Patients M Oshi, S Newman, Y Tokumaru, L Yan, R Matsuyama, I Endo, K Takabe Journal of Immunology Research 2020 (1), 5618786, 2020 | 49 | 2020 |
| Annexin A1 expression is associated with Epithelial–Mesenchymal Transition (EMT), cell proliferation, prognosis, and drug response in pancreatic cancer M Oshi, Y Tokumaru, S Mukhopadhyay, L Yan, R Matsuyama, I Endo, ... Cells 10 (3), 653, 2021 | 47 | 2021 |
| High expression of microRNA-143 is associated with favorable tumor immune microenvironment and better survival in estrogen receptor positive breast cancer Y Tokumaru, M Asaoka, M Oshi, E Katsuta, L Yan, S Narayanan, N Sugito, ... International journal of molecular sciences 21 (9), 3213, 2020 | 47 | 2020 |
| High expression of miR-34a associated with less aggressive cancer biology but not with survival in breast cancer Y Tokumaru, E Katsuta, M Oshi, JC Sporn, L Yan, L Le, N Matsuhashi, ... International journal of molecular sciences 21 (9), 3045, 2020 | 45 | 2020 |
| ITPKC as a prognostic and predictive biomarker of neoadjuvant chemotherapy for triple negative breast cancer M Oshi, S Newman, V Murthy, Y Tokumaru, L Yan, R Matsuyama, I Endo, ... Cancers 12 (10), 2758, 2020 | 41 | 2020 |
Kazuaki Takabe MD PhD FACSRoswell Park Cancer Instituteכתובת אימייל מאומתת בדומיין roswellpark.org
